Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Clinical trial NCT05775159 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05775159
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2026-10-27
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.